Health Oct 06 High cost of GLP-1s drives some to seek cheaper, unregulated versions By Stephanie Sy, Sam Lane, Mike Fritz
Health Jun 19 Watch 7:40 Research shows weight-loss drugs may also reduce cancer risk A growing body of research suggests popular weight-loss drugs like Ozempic and Wegovy may also help treat or prevent certain cancers. It’s the latest unexpected benefit to be associated with GLP-1s, which are now taken by one-in-eight American adults. William… By William Brangham, Jackson Hudgins
Health Apr 02 Diabetes advocates hold out hope as a bipartisan bill revives efforts to lower insulin costs A bipartisan group of senators is aiming to relieve high insulin costs with the INSULIN Act, a bill to cap the cost of the lifesaving drug at $35 per month for Americans with private insurance plans. By Ali Swenson, Associated Press
Health Mar 05 Novo Nordisk cuts Wegovy prices, following Eli Lilly on Zepbound The new monthly price of $499, down from $650, takes effect immediately. By Associated Press
Health Nov 23 Worried about the sugar in your cranberry sauce? A food scientist shares how to cook with fewer added sweeteners Lots of the healthy raw ingredients used in holiday foods can end up overshadowed by sugar and starch, but with a few science-backed culinary tricks, you can make a delicious cranberry dish that’s Type 1 diabetes-friendly. By Rosemary Trout, The Conversation
Aug 15 Here's a list of drugs affected by Biden's latest Medicare pharmaceutical price cuts By Associated Press The savings range from 79 percent for Januvia, a drug to treat diabetes, to 38 percent for Imbruvica, which is used to treat blood cancers. Continue reading
Jan 16 Watch 8:25 New law caps insulin prices for some with diabetes, but cost remains high for others By Laura Barrón-López, Shrai Popat Diabetics will now see a break in their out-of-pocket costs for insulin. Sanofi, one of the leading manufacturers of the hormone, joined two other major pharmaceutical companies in capping their insulin copays at $35. This comes after years of pressure… Continue watching
Apr 20 Watch 8:28 Diabetes a major factor behind declining life expectancy in rural areas By Dr. Alok Patel and Caleb Hellerman, Global Health Reporting Center Over the past two decades, life expectancy in rural areas has declined. One major reason is the prevalence of diabetes. With support from the Pulitzer Center and in collaboration with the Global Health Reporting Center, special correspondent Dr. Alok Patel… Continue watching
Mar 01 Watch 5:12 Pharmaceutical giant slashes insulin prices after pressure from government and consumers By Geoff Bennett, Courtney Norris More than seven million Americans rely on insulin and prices for the life-saving drug have sky-rocketed. With pressure mounting on pharmaceutical companies to address the cost of diabetes care, Eli Lilly announced it’s cutting prices for its most popular insulin… Continue watching
Feb 09 Watch 9:31 Cash-strapped health care facilities work to stave off projected spike in heart disease By Stephanie Sy, Sam Weber, Henry Brannan No disease kills more Americans annually than heart disease. At least half of all Americans are at risk because of factors such as obesity, elevated blood pressure, high cholesterol or smoking. It's projected to get even worse in the coming… Continue watching